Literature DB >> 12097550

Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection.

Jiehao Zhou1, Stephen A Stohlman, Roscoe Atkinson, David R Hinton, Norman W Marten.   

Abstract

The relationship(s) between viral virulence and matrix metalloproteinase (MMP) expression in the central nervous system (CNS) of mice undergoing lethal and sublethal infections with neurotropic mouse hepatitis virus was investigated. Lethal infection induced increased levels of MMP-3 and MMP-12 mRNAs as well as that of tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) compared to sublethal infection. Increased induction of MMP, TIMP, and chemokine expression correlated with increased virus replication but not with inflammatory cell infiltration. Infection of immunosuppressed mice suggested that expression of most MMP, TIMP, and chemokine mRNA was induced primarily in CNS-resident cells. By contrast, MMP-9 protein activity was associated with the infiltration of neutrophils into the CNS. These data indicate an association between the magnitude of inflammatory gene expression within the CNS and viral virulence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097550      PMCID: PMC136378          DOI: 10.1128/jvi.76.15.7374-7384.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

Review 1.  MHV infection of the CNS: mechanisms of immune-mediated control.

Authors:  N W Marten; S A Stohlman; C C Bergmann
Journal:  Viral Immunol       Date:  2001       Impact factor: 2.257

Review 2.  The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system.

Authors:  H P Hartung; B C Kieseier
Journal:  J Neuroimmunol       Date:  2000-07-24       Impact factor: 3.478

Review 3.  Gelatinase B functions as regulator and effector in leukocyte biology.

Authors:  G Opdenakker; P E Van den Steen; B Dubois; I Nelissen; E Van Coillie; S Masure; P Proost; J Van Damme
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

4.  Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversity.

Authors:  J B Johnston; Y Jiang; G van Marle; M B Mayne; W Ni; J Holden; J C McArthur; C Power
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Multiple sclerosis: pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-beta.

Authors:  V Ozenci; M Kouwenhoven; N Teleshova; M Pashenkov; S Fredrikson; H Link
Journal:  J Neuroimmunol       Date:  2000-08-01       Impact factor: 3.478

6.  Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis.

Authors:  R Lichtinghagen; T Seifert; A Kracke; S Marckmann; U Wurster; F Heidenreich
Journal:  J Neuroimmunol       Date:  1999-09-01       Impact factor: 3.478

7.  T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease.

Authors:  P Giraudon; R Szymocha; S Buart; A Bernard; L Cartier; M F Belin; H Akaoka
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

8.  Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts.

Authors:  M Bond; A H Baker; A C Newby
Journal:  Biochem Biophys Res Commun       Date:  1999-10-22       Impact factor: 3.575

9.  Contributions of CD8+ T cells and viral spread to demyelinating disease.

Authors:  N W Marten; S A Stohlman; R D Atkinson; D R Hinton; J O Fleming; C C Bergmann
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

Review 10.  Inflammatory mediators and modulation of blood-brain barrier permeability.

Authors:  N J Abbott
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

View more
  28 in total

1.  Expression of the mouse hepatitis virus receptor by central nervous system microglia.

Authors:  Chandran Ramakrishna; Cornelia C Bergmann; Kathryn V Holmes; Stephen A Stohlman
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis.

Authors:  Jiehao Zhou; Norman W Marten; Cornelia C Bergmann; Wendy B Macklin; David R Hinton; Stephen A Stohlman
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells.

Authors:  Andries Zijlstra; Marco Seandel; Tatyana A Kupriyanova; Juneth J Partridge; Mark A Madsen; Elizabeth A Hahn-Dantona; James P Quigley; Elena I Deryugina
Journal:  Blood       Date:  2005-09-20       Impact factor: 22.113

Review 4.  The pathogenesis of murine coronavirus infection of the central nervous system.

Authors:  Thomas E Lane; Martin P Hosking
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

5.  Excess neutrophil infiltration during cytomegalovirus brain infection of interleukin-10-deficient mice.

Authors:  Manohar B Mutnal; Maxim C-J Cheeran; Shuxian Hu; Morgan R Little; James R Lokensgard
Journal:  J Neuroimmunol       Date:  2010-07-24       Impact factor: 3.478

6.  The role of the blood-brain barrier during Venezuelan equine encephalitis virus infection.

Authors:  Alexandra Schäfer; Christopher B Brooke; Alan C Whitmore; Robert E Johnston
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

7.  The Biology of Persistent Infection: Inflammation and Demyelination following Murine Coronavirus Infection of the Central Nervous System.

Authors:  Martin P Hosking; Thomas E Lane
Journal:  Curr Immunol Rev       Date:  2009-05-04

8.  Mouse hepatitis virus infection of the CNS: a model for defense, disease, and repair.

Authors:  Chris S Schaumburg; Katherine S Held; Thomas E Lane
Journal:  Front Biosci       Date:  2008-05-01

Review 9.  Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.

Authors:  Brett S Marro; Caroline A Blanc; Jeanne F Loring; Michael D Cahalan; Thomas E Lane
Journal:  Expert Rev Neurother       Date:  2014-10       Impact factor: 4.618

10.  A protective role for ELR+ chemokines during acute viral encephalomyelitis.

Authors:  Martin P Hosking; Liping Liu; Richard M Ransohoff; Thomas E Lane
Journal:  PLoS Pathog       Date:  2009-11-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.